InvestorsHub Logo
Followers 12
Posts 406
Boards Moderated 0
Alias Born 03/01/2024

Re: NeutrinoKid post# 45344

Wednesday, 05/15/2024 4:11:14 PM

Wednesday, May 15, 2024 4:11:14 PM

Post# of 50075
Yeah, I think I read that about the CX- in my DD review. I have not seen anything similar for KRM-II-81, not to say that it wont have any issues in human clinicals, but I think it is similar enough to current treatments only with much less deficiency in performance.

To me the most valuable programs in motion is the KRM-II-81 and then the OSA programs. BP/Funding is required to push these into human trials I believe. They seem to be having positive traction but who knows...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News